908 Devices jumps as Repligen buys bioprocessing analytics portfolio

Stock Information for 908 Devices Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About 908 Devices Inc.

908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices
908 Devices to Participate in Upcoming Investor Conferences
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
908 Devices Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results
Getinge and 908 Devices Partner to Enhance Bioreactor Capabilities for Continuous Monitoring of Key Cell Culture Parameters
908 Devices Reports Third Quarter 2024 Financial Results and Updates 2024 Revenue Outlook

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.